article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

While the CRO category includes hundreds of small players, a handful of larger companies like, Parexel, PPD and others like Covance, ICON and Charles River Labs have grown into big multinational groups, often through serial acquisitions of their smaller counterparts.

article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

Challenges in outsourcing drug discovery. In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring. . The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time.

Reagent 52
article thumbnail

Modernizing Pharmacovigilance Outsourcing

XTalks

Companies outsource to gain access to specialized expertise and technology, scale pharmacovigilance (PV) activities, and reduce costs. However, the efficiency and effectiveness of externalized safety activities are below expectations for many biotech and pharma companies.